Rezension:
I\'m sorry, he\'s test freak testosterone supplements The results are consistent with earlier-stage studies and still need to be confirmed in multiple trials of different patient populations before the companies will seek regulatory approval, said Regeneron President and Chief Scientific Officer George D. Yancopoulos. The companies are aiming to file for approval with the U.S. Food and Drug Administration toward the end of 2015, he said, with a possible approval coming in 2016.
